Disease Info Card

5,10-methylenetetrahydrofolate Reductase Deficiency

Information about 5,10-methylenetetrahydrofolate Reductase Deficiency: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of 5,10-methylenetetrahydrofolate Reductase Deficiency

Most recent studies have shown that 5,10-methylenetetrahydrofolate Reductase Deficiency shares some biological mechanisms with atherosclerosis, cardiovascular-diseases, cerebrovascular-accident, cholangiocarcinoma, colorectal-cancer, colorectal-neoplasms, coronary-artery-disease, diabetes-mellitus, folic-acid-deficiency, hyperhomocysteinemia, hypertensive-disease, infarction, leukemia, malignant-neoplasms, neoplasms, thromboembolism, thrombophilia, thrombosis, vascular-diseases, venous-thrombosis.

Among the many pathways, these few ones have gauged particular interests from scientists studying 5,10-methylenetetrahydrofolate Reductase Deficiency, and have been seen in publications frequently: Aging, Blood Coagulation, Cell Proliferation, Coagulation, Cognition, Dna Hypomethylation, Dna Methylation, Dna Repair, Excretion, Fibrinolysis, Glomerular Filtration, Hemostasis, Meiosis, Menopause, Methylation, Pathogenesis, Platelet Aggregation, Spermatogenesis, Transport, Transsulfuration

Quite a number of genes have been found to play important roles in 5,10-methylenetetrahydrofolate Reductase Deficiency, such as ACE, APOE, CACNA1C, CBS, F2, F5, GSTM1, MTHFR, MTR, MTRR, NOS3, RFC1, SERPINE1, SHMT1, SLC19A1, TBXAS1, TEAD1, TYMS. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.